ClearEpi™ SARS-CoV-2 Neutralizing Antibody Rapid Test
Catalogue No.: CBB-F016031-BLD-C


Neutralizing Antibody (nAB) Test Kit

  • Qualitative detection of circulating human IgG neutralizing antibodies (nAbs) that block the interaction between the receptor binding domain (RBD) of the SARS-CoV-2 spike protein with the cell surface ACE2 receptor
  • May aid in evaluating individuals' immune response after vaccination (14-28 days after completing vaccination schedule)
  • May aid in post-vaccination monitoring to indicate when booster shot is needed
  • Convenient storage conditions: 4°C - 30°C
European CE Marking

Test Procedure and Result Interpretation

Add three (3) drops of sample to the sample well of the cassette using the provided dropper.
Read results after 15 minutes. DO NOT read the results after 20 minutes. *Results read after 20 minutes are invalid.
Positive result is indicated by a faint or absent Test line (T) with a colored Control line (C). Positive results indicate the presence of SARS- CoV-2 neutralizing antibodies.
Negative result is indicated by a colored Test line (T) with a colored Control line (C). Negative results indicate the absence of SARS- CoV-2 neutralizing antibodies

Neutralizing Antibody Test

Neutralising antibodies (nAb) are antibodies that protect the body from infection through the binding to the pathogen (such as bacteria and viruses) and directly interfere with their infectivity.

Catalogue Number Test Type Test Method Test Method  
CBB-F016031-BLD-C Neutralizing Antibody Test - LFA - LFA Product Inquiry Form
Locate Us
Contact Us